- Home
- NVCT vs CADL Comparison
NVCT vs CADL Comparison
Compare NVCT & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVCT
- CADL
- Stock Information
- Founded
- NVCT 2020
- CADL 1999
- Country
- NVCT United States
- CADL United States
- Employees
- NVCT N/A
- CADL N/A
- Industry
- NVCT Medicinal Chemicals and Botanical Products
- CADL Biotechnology: Pharmaceutical Preparations
- Sector
- NVCT Health Care
- CADL Health Care
- Exchange
- NVCT Nasdaq
- CADL Nasdaq
- Market Cap
- NVCT 249.1M
- CADL 234.8M
- IPO Year
- NVCT 2022
- CADL 2021
- Fundamental
- Price
- NVCT $8.99
- CADL $4.81
- Analyst Decision
- NVCT Strong Buy
- CADL Strong Buy
- Analyst Count
- NVCT 3
- CADL 4
- Target Price
- NVCT $17.00
- CADL $21.00
- AVG Volume (30 Days)
- NVCT 157.3K
- CADL 843.6K
- Earning Date
- NVCT 05-06-2025
- CADL 05-20-2025
- Dividend Yield
- NVCT N/A
- CADL N/A
- EPS Growth
- NVCT N/A
- CADL N/A
- EPS
- NVCT N/A
- CADL N/A
- Revenue
- NVCT N/A
- CADL N/A
- Revenue This Year
- NVCT N/A
- CADL N/A
- Revenue Next Year
- NVCT N/A
- CADL N/A
- P/E Ratio
- NVCT N/A
- CADL N/A
- Revenue Growth
- NVCT N/A
- CADL N/A
- 52 Week Low
- NVCT $4.44
- CADL $3.79
- 52 Week High
- NVCT $11.80
- CADL $14.60
- Technical
- Relative Strength Index (RSI)
- NVCT 47.46
- CADL 42.39
- Support Level
- NVCT $8.01
- CADL $4.34
- Resistance Level
- NVCT $9.62
- CADL $5.34
- Average True Range (ATR)
- NVCT 1.04
- CADL 0.33
- MACD
- NVCT -0.16
- CADL 0.10
- Stochastic Oscillator
- NVCT 27.96
- CADL 47.11
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.